HomeNGEN • CVE
add
NervGen Pharma Corp
Nakaraang pagsara
$3.00
Sakop ng araw
$2.96 - $3.00
Sakop ng taon
$1.65 - $3.36
Market cap
212.98M CAD
Average na Volume
58.79K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Barron's
30 minuto ang nakalipas
S&P 500 Futures Rise in Premarket Trading; McCormick Vtg, Glaukos Lag
0.15%
0.53%
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 6.81M | 39.61% |
Net na kita | -8.61M | -0.00% |
Net profit margin | — | — |
Kita sa bawat share | -0.14 | — |
EBITDA | -6.79M | -39.75% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 17.27M | 48.10% |
Kabuuang asset | 19.49M | 47.22% |
Kabuuang sagutin | 16.91M | 10.92% |
Kabuuang equity | 2.58M | — |
Natitirang share | 70.99M | — |
Presyo para makapag-book | 75.00 | — |
Return on assets | -81.13% | — |
Return on capital | -283.82% | — |
Cash Flow
Net change in cash
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -8.61M | -0.00% |
Cash mula sa mga operasyon | -3.66M | -18.58% |
Cash mula sa pag-invest | 25.23K | 2,523,100.00% |
Cash mula sa financing | 310.00K | 314.61% |
Net change in cash | -3.74M | -19.66% |
Malayang cash flow | 277.72K | -88.22% |
Tungkol
Itinatag
2017
Headquarters
Website
Mga Empleyado
10
